Literature DB >> 3958145

Design and analysis considerations in evaluating the chemiluminescence response of mouse spleen cells.

D M Giltinan, T P Capizzi, G K Abruzzo, R A Fromtling.   

Abstract

Chemiluminescence is the result of the respiratory burst generated by phagocytic cells after stimulation by antigen. The measurement of chemiluminescence represents a sensitive means for detecting antigenic stimulation and immune cell function. Although the kinetics of chemiluminescence reactions have been described, appropriate statistical methods for the evaluation of data from chemiluminescence assays have not been reported. Based on examination of data from several studies in which the chemiluminescence response of spleen cells was investigated after stimulation with the particulate antigen zymosan, recommendations are made for the design and statistical evaluation of such studies. Three parameters were used in assessing the chemiluminescence response; peak intensity of the emitted light, time to peak, and the area under the intensity-time curve. The data indicated that peak intensity alone provides an adequate characterization of the chemiluminescence response. Since percent change in response upon treatment is of interest, analysis on the log scale is appropriate, and the statistical procedure of choice in evaluating data of this type is a trend analysis. The need for a balanced allocation of treatments to avoid potential bias is demonstrated. The methods proposed are illustrated with data from two studies in which the effect of preincubation with low concentrations of ketoconazole, an antifungal agent, on the chemiluminescence response of BALB/cBY spleen cells was examined.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958145      PMCID: PMC268688          DOI: 10.1128/jcm.23.3.531-535.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

2.  Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity.

Authors:  R C Allen; R L Stjernholm; R H Steele
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

3.  Mechanism of the luminol-dependent chemiluminescence of human neutrophils.

Authors:  L R DeChatelet; G D Long; P S Shirley; D A Bass; M J Thomas; F W Henderson; M S Cohen
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

4.  Testing the statistical certainty of a response to increasing doses of a drug.

Authors:  J W Tukey; J L Ciminera; J F Heyse
Journal:  Biometrics       Date:  1985-03       Impact factor: 2.571

5.  Effect of uremia on lymphocyte transformation and chemiluminescence by spleen cells of normal and Cryptococcus neoformans-infected mice.

Authors:  R A Fromtling; A M Fromtling; F Staib; S Müller
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

6.  Measurement of chemiluminescence in freshly drawn human blood. II. Clinical application of zymosan-induced chemiluminescence.

Authors:  M Heberer; M Ernst; M Dürig; M Allgöwer; H Fischer
Journal:  Klin Wochenschr       Date:  1982-12-01

7.  Assessing laboratory evidence for neoplastic activity.

Authors:  N Mantel
Journal:  Biometrics       Date:  1980-09       Impact factor: 2.571

8.  Effect of antimicrobial agents on human polymorphonuclear leukocyte microbicidal function.

Authors:  W D Welch; D Davis; L D Thrupp
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

  8 in total
  1 in total

1.  Influence of six antifungal agents on the chemiluminescence response of mouse spleen cells.

Authors:  G K Abruzzo; D M Giltinan; T P Capizzi; R A Fromtling
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.